Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00902590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT00902590 · ClinicalTrials.gov record · last posted 2026-08-24

A Genotype-Phenotype Urothelial Cancer Registry

StatusActive, Not Recruiting
PhaseNot specified
Started2009-05
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is being done to create a registry to help us learn more about urinary and other cancers. This will let us look at large groups of people who do and do not have this kind of cancer. The investigators will look at risk factors to learn more about how these impact cancer. The investigators will also look at genetic markers. These are genes that are found in a known place. They are often associated with a particular trait. If the gene changes in some way, it may predict cancer or response to treatment. The investigators will look for markers in your saliva. This registry will help us develop better methods of: Preventing these cancers. Diagnosing these cancers. Treating these cancers.

Protocol amendment history 2 changes detected by DataLookout

2026-08-25
critical
Primary completion pushed: 2026-05-31 → 2027-05-31
2026-08-25
minor
Completion pushed: 2026-05-31 → 2027-05-31
Trial Details
NCT Number NCT00902590
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: University of Chicago, Fox Chase Cancer Center
Conditions Urothelial Cancer, Renal Pelvis Cancer, Ureter Cancer, Bladder Cancer
Enrollment 3,519 participants
Start Date 2009-05
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-24